Cite
ADVERSE CARDIOVASCULAR EVENTS ASSOCIATED WITH KINASE INHIBITORS IN THE TREATMENT OF CANCER REVEAL SPECIFIC RISK BASED ON THE KINASE INHIBITOR - A SINGLE-CENTER RETROSPECTIVE COHORT STUDY.
MLA
Kwan, Jennifer, et al. “Adverse Cardiovascular Events Associated with Kinase Inhibitors in the Treatment of Cancer Reveal Specific Risk Based on the Kinase Inhibitor - a Single-Center Retrospective Cohort Study.” Journal of the American College of Cardiology (JACC), vol. 79, no. 9, Mar. 2022, p. 1924. EBSCOhost, https://doi.org/10.1016/S0735-1097(22)02915-1.
APA
Kwan, J., Shen, M., Mankbadi, M., Wang, P., Zaman, S., Lee, S., Jiang, M., Tao, W., Wei, W., & Akhlaghi, N. (2022). Adverse Cardiovascular Events Associated with Kinase Inhibitors in the Treatment of Cancer Reveal Specific Risk Based on the Kinase Inhibitor - a Single-Center Retrospective Cohort Study. Journal of the American College of Cardiology (JACC), 79(9), 1924. https://doi.org/10.1016/S0735-1097(22)02915-1
Chicago
Kwan, Jennifer, Miles Shen, Michael Mankbadi, Peter Wang, Saif Zaman, Seohyuk Lee, Matthew Jiang, Weiwei Tao, Wei Wei, and Narjes Akhlaghi. 2022. “Adverse Cardiovascular Events Associated with Kinase Inhibitors in the Treatment of Cancer Reveal Specific Risk Based on the Kinase Inhibitor - a Single-Center Retrospective Cohort Study.” Journal of the American College of Cardiology (JACC) 79 (9): 1924. doi:10.1016/S0735-1097(22)02915-1.